Structural analysis of the epitope of the anti-HIV mAb 2F5 sheds light into its mechanism of neutralization and HIV fusion

被引:0
|
作者
Pessi, A
Barbato, G
Ingallinella, P
Hurni, WH
Miller, MD
Ciliberto, G
Cortese, R
Bazzo, R
Shiver, JW
Bianchi, E
机构
[1] IRBM, Merck Res Labs, I-00040 Rome, Italy
[2] Merck Res Labs, W Point, PA 19486 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
O68
引用
收藏
页码:299 / 300
页数:2
相关论文
共 50 条
  • [1] Structural analysis of the epitope of the anti-HIV MAB 2F5 sheds light into its mechanism of neutralization and HIV fusion
    Pessi, A
    Barbato, G
    Ingallinella, P
    Hurni, WH
    Miller, MD
    Ciliberto, G
    Cortese, R
    Bazzo, R
    Shiver, JW
    Bianchi, E
    CHIMICA OGGI-CHEMISTRY TODAY, 2003, 21 (06) : 10 - 15
  • [2] Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
    Barbato, G
    Bianchi, E
    Ingallinella, P
    Hurni, WH
    Miller, MD
    Cilibertol, G
    Cortese, R
    Bazzo, R
    Shiver, JW
    Pessi, A
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) : 1101 - 1115
  • [3] Structural analysis of the epitope of the anti-HIV-1 mAb 2F5 yields insights into the mechanism of neutralization and into the HIV-1 fusion process
    Pessi, Antonello
    Barbato, Gaetano
    Ingallinella, Paolo
    Hurni, William H.
    Miller, Michael D.
    Ciliberto, Gennaro
    Cortese, Riccardo
    Bazzo, Renzo
    Shiver, John W.
    Bianchi, Elisabetta
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 978 - 980
  • [4] Interaction of Anti-HIV Type 1 Antibody 2F5 with Phospholipid Bilayers and Its Relevance for the Mechanism of Virus Neutralization
    Maeso, Ruben
    Huarte, Nerea
    Julien, Jean-Philippe
    Kunert, Renate
    Pai, Emil F.
    Nieva, Jose L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (08) : 863 - 876
  • [5] -2 Degradation of anti-HIV antibodies 2F5 and PG9 by proteases of Nicotiana benthamiana
    Puchol-Tarazona, A.
    Paireder, M.
    Taubenschmid, Y.
    Maresch, D.
    Mach, L.
    NEW BIOTECHNOLOGY, 2018, 44 : S26 - S26
  • [6] A small phase I clinical trial with the human anti-HIV-1 mAb 2F5
    Katinger, H
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 291 - 297
  • [7] Fusion Peptide Effects on Epitope Recognition At Membrane Surfaces by the Broadly Neutralizing Anti-HIV-1 2f5 Monoclonal Antibody
    Huarte, Nerea
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 91A - 91A
  • [8] Fusion peptide effects on epitope recognition at membrane surfaces by the broadly neutralizing anti-HIV-1 2F5 monoclonal antibody
    Huarte, Nerea
    Araujo, Aitziber
    Arranz, Rocio
    Valpuesta, Jose M.
    Nieva, Jose L.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2010, 163 : S51 - S51
  • [9] Characterization of antibody responses against the 2F5 epitope ELDKWA sing HIV-1 Env-mediated membrane fusion and neutralization assays
    Cao Y.
    Chen Y.
    Tsinghua Science and Technology, 2010, 15 (04) : 447 - 451